ATLANTIC AMERICAN CORP (AAME) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US0482091008
ATLANTIC AMERICAN CORP financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 210.44 m USD |
| Operating income | 3.70 m USD |
| EBIT | 10.80 m USD |
| Net income | 6.02 m USD |
| Diluted EPS – continuing operations | 0.28 USD |
Full history since 1985, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ATLANTIC AMERICAN CORP
Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. It operates through American Southern and Bankers Fidelity segments. The company offers property and casualty insurance products, including commercial automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; general liability insurance; and inland marine insurance products. It also provides surety bond coverage for subdivision construction; school bus contracts; and performance and payment bonds. In addition, the company offers individual and group whole life insurance products; Medicare supplement insurance products; other accident and health insurance products comprising various individual and group policies for the payment of standard benefits for the treatment of cancer and other critical illnesses; Vantage Flex Plus, a hospital indemnity plan; and Vantage Recovery short-term care product and a group whole life product. It markets its products through independent agents and brokers. The company was founded in 1937 and is based in Atlanta, Georgia. Atlantic American Corporation operates as a subsidiary of Atlantic American / Delta Group.
More stocks
- Edesa Biotech, Inc. (EDSA)
- Adicet Bio, Inc. (ACET)
- AMERICAN VANGUARD CORP (AVD)
- Metagenomi Therapeutics, Inc. (MGX)
- Xos, Inc. (XOS)
- Mono Next Public Company Limited (MONO.BK)
- Tonix Pharmaceuticals Holding Corp. (TNXP)
- CervoMed Inc. (CRVO)
- Lite Strategy, Inc. (LITS)
- Bio Essence Corp (BIOE)
- Scientist Home Future Health Ltd (SHFH)
- ConnectM Technology Solutions, Inc. (CNTM)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.